Expression of calreticulin is associated with infiltration of T-cells in stage IIIB colon cancer
about
Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in CancerReview of Cisplatin and oxaliplatin in current immunogenic and monoclonal antibody treatmentsImmunogenic versus tolerogenic phagocytosis during anticancer therapy: mechanisms and clinical translationBiomarkers of immunogenic stress in metastases from melanoma patients: Correlations with the immune infiltrateDAMPs and PDT-mediated photo-oxidative stress: exploring the unknown.Calreticulin down-regulation inhibits the cell growth, invasion and cell cycle progression of human hepatocellular carcinoma cells.Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removalProteomic screening identifies calreticulin as a miR-27a direct target repressing MHC class I cell surface exposure in colorectal cancer.Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy.Calreticulin expression: Interaction with the immune infiltrate and impact on survival in patients with ovarian and non-small cell lung cancer.Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients.Immune parameters affecting the efficacy of chemotherapeutic regimens.A stressful microenvironment: opposing effects of the endoplasmic reticulum stress response in the suppression and enhancement of adaptive tumor immunity.Calreticulin, a therapeutic target?The miR-27a-calreticulin axis affects drug-induced immunogenic cell death in human colorectal cancer cellsOmega 3 fatty acids chemosensitize multidrug resistant colon cancer cells by down-regulating cholesterol synthesis and altering detergent resistant membranes composition.Immunological metagene signatures derived from immunogenic cancer cell death associate with improved survival of patients with lung, breast or ovarian malignancies: A large-scale meta-analysisTumor-infiltrating memory T-lymphocytes for prognostic prediction in cancer patients: a meta-analysisInvolvement of damage-associated molecular patterns in tumor response to photodynamic therapy: surface expression of calreticulin and high-mobility group box-1 release.Review of Cisplatin and Oxaliplatin in Current Immunogenic and Monoclonal Antibodies Perspective.Immunogenic and Non-immunogenic Cell Death in the Tumor Microenvironment.Monitoring the responsiveness of T and antigen presenting cell compartments in breast cancer patients is useful to predict clinical tumor response to neoadjuvant chemotherapy.Expression and significance of calreticulin in human osteosarcoma.Primary glioblastoma multiforme tumors and recurrence : Comparative analysis of the danger signals HMGB1, HSP70, and calreticulin.Reporting in studies of protein biomarkers of prognosis in colorectal cancer in relation to the REMARK guidelines.Significance of calreticulin as a prognostic factor in endometrial cancer.DNA damage predicts prognosis and treatment response in colorectal liver metastases superior to immunogenic cell death and T cells.Identification of PGAM1 as a putative therapeutic target for pancreatic ductal adenocarcinoma metastasis using quantitative proteomics.Immunogenic effects of chemotherapy-induced tumor cell death
P2860
Q26795466-063CDDD5-D4A3-4994-A224-171378911928Q28082382-B6E47002-6E3F-4524-8771-9F8D5C48EE57Q28386858-EF40B172-F8A8-4485-B38D-64CA3E3A2885Q30276247-B3E3FE21-85BF-449D-90C6-2408196983D6Q34160434-59CE71FB-BBC6-46D7-9683-EA778FE71E15Q35996901-F387E6DD-B17D-4CD8-A5E1-B86770E98F90Q36413628-1ACC6EDB-1DAF-4103-A81B-BCC32C9A998EQ36847539-A42BA3D0-0C9E-4945-B4C7-30F75853D8A8Q37078968-59C97452-4DDF-49B5-9D72-14A771789EDCQ37222093-624C4797-0C45-458A-81DF-BAFF1C7DC49FQ37545824-A2D969CE-BB7A-4068-920A-F299214EDC29Q37848665-7854E734-13B4-4058-9227-BC3D361E5DE6Q38379620-C22132D3-5019-40E3-B9C6-746B7684DFCFQ38766974-DE839E1C-65D1-4A42-841E-32FD781A3831Q38791198-C6750304-BED3-4FF2-83E5-E74E47ABEEB7Q39063524-23DCB5ED-1B9A-48A9-8D1E-367C25D77280Q39281286-304C24E8-5833-4525-B77E-949DFDF1251CQ39777761-AF7AA023-E1FB-4B52-ACE8-CA499456D1D8Q44035557-7319344F-FA34-4B16-ACAF-9E95E4793B07Q44242635-DE2E2741-B034-4906-9714-2727E7CED37BQ49592900-205096AC-B7E9-43BA-A37E-70A6F4757878Q50044364-F36E4B6A-042D-4A2B-B025-2DB301AD5ADCQ51179296-B9A82DE1-C7EB-41C4-9F3E-0187D657DC47Q52145169-712C5A2C-F48E-43B2-AF56-3F07C1CAAEFEQ53584232-DD810B4F-99D2-4593-8CE1-1E0C62373F4EQ54977789-6EAAC183-8158-41CC-91F4-6F13AA608A1AQ55223036-1DACFE71-919C-46A0-8A47-AAF775EEAEB0Q55252749-163433E6-52C8-44C4-AEAA-F15C1B3C6081Q57497508-C175B400-FA51-4D78-843D-686F62F9FAAF
P2860
Expression of calreticulin is associated with infiltration of T-cells in stage IIIB colon cancer
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Expression of calreticulin is ...... lls in stage IIIB colon cancer
@ast
Expression of calreticulin is ...... lls in stage IIIB colon cancer
@en
Expression of calreticulin is ...... lls in stage IIIB colon cancer
@nl
type
label
Expression of calreticulin is ...... lls in stage IIIB colon cancer
@ast
Expression of calreticulin is ...... lls in stage IIIB colon cancer
@en
Expression of calreticulin is ...... lls in stage IIIB colon cancer
@nl
prefLabel
Expression of calreticulin is ...... lls in stage IIIB colon cancer
@ast
Expression of calreticulin is ...... lls in stage IIIB colon cancer
@en
Expression of calreticulin is ...... lls in stage IIIB colon cancer
@nl
P2093
P2860
P356
P1476
Expression of calreticulin is ...... lls in stage IIIB colon cancer
@en
P2093
Rong Zhang
Rui-Qing Peng
Xiao-Shi Zhang
Xing Zhang
Xing-Juan Yu
Yi-Xin Zeng
Ying-Bo Chen
Zhi-Wei Zhou
P2860
P304
P356
10.3748/WJG.V16.I19.2428
P407
P577
2010-05-21T00:00:00Z